Insider Trading History of Column Group Llc

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Column Group Llc since 2021. This trader's CIK number is 1833486. At the time of last reporting, Column Group Llc was the 10% Owner of Rapt Therapeutics, Inc.. (stock ticker symbol RAPT). Also see all insider trading activities at Rapt Therapeutics, Inc..

Note that in the past Column Group LLC also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Rapt Therapeutics, Inc. (RAPT) by Column Group Llc

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2022 RAPT 1,250,000 $13,340,000 0 $0 0 $0
2021 RAPT 0 $0 391,101 $13,699,874 9,239 $214,871

Yearly summary of insider trading at Oric Pharmaceuticals, Inc. (ORIC) by Column Group Llc

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2021 ORIC 0 $0 0 $0 16,625 $266,000


Insider trading activities at 2 companies by Column Group Llc:

1. Rapt Therapeutics, Inc. (RAPT)

2. Oric Pharmaceuticals, Inc. (ORIC)

Table 1. Insider trading of Rapt Therapeutics, Inc. (RAPT) by Column Group Llc

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2022-05-10 RAPT Buy 1,250,000 10.67 13,340,000
2021-09-27 RAPT Option Ex 9,239 23.26 214,871
2021-09-27 RAPT Sale 9,239 34.80 321,489
2021-09-14 RAPT Sale 147,676 36.63 5,409,371
2021-09-15 RAPT Sale 33,535 37.45 1,255,986
2021-09-10 RAPT Sale 21,738 35.19 765,003
2021-09-13 RAPT Sale 14,317 35.27 504,946
2021-09-01 RAPT Sale 31,749 35.23 1,118,549
2021-09-02 RAPT Sale 37,101 35.43 1,314,562
2021-08-20 RAPT Sale 4,539 30.08 136,533
2021-08-23 RAPT Sale 68,340 31.57 2,157,630
2021-08-24 RAPT Sale 22,867 31.30 715,805

Table 2. Insider trading of Oric Pharmaceuticals, Inc. (ORIC) by Column Group Llc

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2021-11-12 ORIC Option Ex 16,625 16.00 266,000

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Column Group Llc (10% Owner of Rapt Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.